Skip to main content

CareDx, Inc (CDNA) Stock Forecast

Data as of May 2, 2026

Healthcare · Current price $21.77 (+4.61%)

Consensus Target
$23.33
Upside
+10.2%
Analysts
5
Rating
Buy(2.40)

Price Target Range

Low $18.00Consensus $23.33High $26.00
▲ Current $21.77

Consensus Price Target Over Time

Analyst Rating Distribution

Last 3 Months

Consensus
Buy
Strong Buy0
Buy2
Hold1
Sell0
Strong Sell0

6-Month Trend

Latest Analyst Forecasts

Price targets issued by Wall Street analysts. Upside calculated against today's price.

DateAnalystFirmPrice TargetUpside
Feb 25, 2026Sung Ji NamBTIG$26.00+19.4%
Dec 15, 2025Brandon CouillardWells Fargo$18.00-17.3%
Nov 5, 2024Sung Ji NamBTIG$35.00+60.8%
Aug 19, 2024Mark MassaroBTIG$40.00+83.7%
Aug 16, 2024Bill BonelloCraig-Hallum$40.00+83.7%
Aug 1, 2024Bill BonelloCraig-Hallum$32.00+47.0%
Apr 17, 2024Mason CarricoStephens$15.00-31.1%

CDNA vs Sector & Market

MetricCDNAHealthcare AvgLarge Cap Avg
Analyst Rating2.402.242.41
Analyst Count5818
Target Upside+10.2%+1150.3%+14.9%
P/E Ratio-52.456.9231.19

Revenue Estimates

PeriodLowAvgHigh#
2026-06-30$102M$107M$114M5
2026-09-30$106M$109M$118M2
2026-12-31$110M$114M$123M2
2027-03-31$109M$113M$121M2
2027-06-30$113M$117M$126M2
2027-09-30$117M$122M$131M2
2027-12-31$123M$127M$137M2
2028-12-31$522M$528M$534M1

EPS Estimates

PeriodLowAvgHigh#
2026-06-30$-0.01$-0.01$-0.014
2026-09-30$0.00$0.01$0.011
2026-12-31$0.02$0.02$0.022
2027-03-31$-0.01$-0.01$-0.012
2027-06-30$0.05$0.05$0.061
2027-09-30$0.08$0.09$0.101
2027-12-31$0.16$0.16$0.182
2028-12-31$0.68$0.69$0.731

Frequently Asked Questions

What is the analyst consensus for CDNA?

The consensus among 5 analysts covering CareDx, Inc (CDNA) is Buy with an average price target of $23.33.

What is the highest price target for CDNA?

The highest price target for CDNA is $40.00, set by Mark Massaro at BTIG on 2024-08-19.

What is the lowest price target for CDNA?

The lowest price target for CDNA is $15.00, set by Mason Carrico at Stephens on 2024-04-17.

How many analysts cover CDNA?

5 analysts have issued ratings for CareDx, Inc in the past 12 months.

Is CDNA a buy or sell right now?

Based on 5 analyst ratings, CDNA has a consensus rating of Buy (2.40/5) with a +10.2% upside to the consensus target of $23.33.

What are the earnings estimates for CDNA?

Analysts estimate CDNA will report EPS of $-0.01 for the period ending 2026-06-30, with revenue estimated at $107M.

Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.